However, from an experimental standpoint, this aspect of the ER+ models had the benefit of negating the anabolic effects of TGFβ inhibition on the bone microenvironment normally seen in naïve or ER- tumor-bearing mice [30,32,48]. Here, TGFB1 is linked to neoplasm.